GlassScriptPhysician profile
James Coan Mcalpine
NPI 1285020958
$3,402.37
in general payments reported to CMS, 2019-2025
50 companies · $537 in 2025
The $537 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $147 · 2021: $466 · 2022: $600 · 2023: $600 · 2024: $635 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,771.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $380.83 | 2019-2025 | Shingrix, Arexvy |
| Lilly USA, LLC | $345.04 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $332.21 | 2020-2025 | Rybelsus, Ozempic, Tresiba |
| Novartis Pharmaceuticals Corporation | $264.50 | 2022-2025 | |
| Amgen INC. | $251.39 | 2019-2025 | Otezla, Repatha, Krystexxa |
| Abbvie INC. | $246.51 | 2021-2025 | |
| Boston Scientific Corporation | $184.86 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $132.84 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $112.21 | 2019-2025 | Airsupra |
| Dexcom, INC. | $109.16 | 2021-2024 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $77.80 | 2020-2025 | Injectafer |
| Amarin Pharma, INC. | $62.78 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $57.98 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.21 | 2024-2025 | Xifaxan |
| Astellas Pharma US INC | $43.64 | 2019-2020 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcalpine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.